{"id":"https://genegraph.clinicalgenome.org/r/82a790c9-0cb4-4f02-b025-7dfb3903df52v1.0","type":"EvidenceStrengthAssertion","dc:description":"MTAP (MethylThioAdenosine Phosphorylase) was first reported in relation to autosomal dominant diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH [MIM 112250]) in 2012 (Camacho-Vanegas et al.,  PMID: 22464254). However, prior to this the critical locus was identified through linkage (Martignetti et al 1999) and reports of the condition had been circulating since its early identification (Arnold, 1973). DMS-MFH presents with unique bone dysplasia phenotypes that result in fractures and poor healing, as well as progressive wasting, cataracts and muscular dystrophy. Approximately 35% of affected individuals develop bone sarcoma. The reported variants are synonymous (predicted silent) variants that affect splicing of the MTAP gene and result in numerous isoforms with negative consequences on MTAP functions. Evidence supporting this gene-disease relationship includes case-level, segregation and experimental data. Variants in MTAP have been reported in at least 5 probands in 1 publication (PMID:22464254) summarizing multiple prior publications. MTAP variants display a clear autosomal dominant inheritance pattern. The mechanism for disease is altered function and is still being investigated. 5.5 points (2.5 points case level data and 3 points segregation) were received in the genetic evidence section. Experimental evidence is limited to 2.75 points including expression studies including RNA analysis from patients, in vitro functional assays and has some support from a mouse model (PMIDs:19567676;22464254;11895909). In addition, around 1/3 of osteosarcomas (35%) display loss of MTAP. While heterozygous knockout of MTAP in mice does not cause osteosarcoma, these mice display T-cell lymphoma and the homozygous knockout is embryonic lethal, which indicates the essential nature of the MTAP gene. In summary, there is moderate evidence to support the relationship between MTAP and diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/82a790c9-0cb4-4f02-b025-7dfb3903df52","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2021-06-15T23:29:51.915Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2021-06-15T23:30:03.170Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04770843-6639-4284-bab3-10b67dc7a36e","type":"EvidenceLine","dc:description":"The experiment shows loss of MTAP function, embryonic lethality for homozygous mice and T-cell lymphoma in heterozygotes, but it does not 1. replicate skeletal neoplasia or 2. test the same variants observed in affected families. Reduced score to 1 to account for these factors. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b19af4fc-7050-4757-ad5a-2fabdd5cc9cd","type":"Finding","dc:description":"The mouse cancer (T-cell lymphoma) does not resemble the human cancer (skeletal neoplasia), but the embryonic lethality of homozygotes displays that MTAP is an essential gene, and MTAP loss causes unchecked cell growth. Scoring was downgraded accordingly for these discrepancies.   ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19567676","rdfs:label":"MTAP Knockout and Heterozygous Mice ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/669388f0-a268-463b-83cd-065bfa1d5ea6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a15a4c4-49d1-4e21-9e58-f1abf792d1da","type":"FunctionalAlteration","dc:description":"The WT produces multiple isoforms of MTAP gene while the variant alleles produce single or limited isoforms and show complete loss of other isoforms. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"RNA Splicing in Patient Derived Cell Lines "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a4d38f3-6c24-4bc2-9dfd-0429e21b3508","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54ae19a0-5191-4208-b553-e37d0c8fcf96","type":"Finding","dc:description":"MTA is present in the serum due to damaging mutation in MTAP and inability to metabolize MTA. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"MTA Serum Levels in Affected Probands ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e069558f-d3f5-4070-a928-eaeba7806195","type":"EvidenceLine","dc:description":"Downgrade because (1) only around 1/3 of the osteocarcomas show loss of MTAP and (2) the deletion size is unknown. The authors used PCR of MTAP exons but did not comment if the deletion was localized to MTAP only or resided in a larger chromosomal deletion.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95fddeb2-f4e3-448b-ad73-a0a110550186","type":"Finding","dc:description":"The authors sampled 96 high grade osteosarcoma tumors for MTAP presence and identified 36 of 96 (37.5%) had at least a partial deletion of the MTAP gene. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11895909","rdfs:label":"MTAP deletion in osteocarcoma tumors ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/6968a729-706c-4efb-bbb9-0aef788ac931","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a57b82a-899d-4929-9b71-dbdd632cf66f","type":"Finding","dc:description":"Compared to controls, patient derived fibroblast and lymphblast cell lines displayed marked alterations in MTAP expression --  expression levels of MTAP_v1 and expression levels of MTAP_v3 and _v6 were approximately 50% lower and nearly five to ten times higher, respectively, than those of the controls. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"MTAP Isoform Expression in Probands ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.25}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.75},{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fefb93e-25d6-4ff3-be40-2b7f923cf81c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e15ba7f-ed77-4eae-be73-fc49a366fb48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"F4(IV-2)","phenotypes":["obo:HP_0002652","obo:HP_0010622"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7fefb93e-25d6-4ff3-be40-2b7f923cf81c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","allele":{"id":"https://genegraph.clinicalgenome.org/r/eedb98dc-0802-4102-8b71-abfc19b5ad5c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MTAP, 885A-G, ARG100ARG","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/29790"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/83bf6e55-ef3e-4223-9efc-aab0e39cace1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ebc5977-2c67-4c41-b70e-01608cb22324","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"F2(V-7)","phenotypeFreeText":"Skeletal dysplasia, bone dysplasia, bone cancer (neoplasm of skeletal system)","phenotypes":["obo:HP_0002652","obo:HP_0010622"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/83bf6e55-ef3e-4223-9efc-aab0e39cace1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2a83b9e-d5c0-40e5-8cda-f75738281da9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MTAP, IVS9AS, A-G, -2","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/29791"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e737b20b-67b2-4558-824e-76a4363c01f0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce6b024b-199f-44c0-b56d-d927b78add1f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"F1(V8)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e737b20b-67b2-4558-824e-76a4363c01f0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","allele":{"id":"https://genegraph.clinicalgenome.org/r/eedb98dc-0802-4102-8b71-abfc19b5ad5c"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/43ced7d0-9ddf-40c1-9584-0b14f85ff5e5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c9ca6be-2216-4209-b7c4-bcc2e6ae90db","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"F5(V-1)","phenotypeFreeText":"HP:0002652","phenotypes":["obo:HP_0002652","obo:HP_0001324","obo:HP_0003084"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/43ced7d0-9ddf-40c1-9584-0b14f85ff5e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2a83b9e-d5c0-40e5-8cda-f75738281da9"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/820a021b-8f37-4ad0-bc90-c5f075b4be56_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/480f0b36-a422-45a9-9f8d-b74c1237d760","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"F3(IV-8)","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/820a021b-8f37-4ad0-bc90-c5f075b4be56_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","allele":{"id":"https://genegraph.clinicalgenome.org/r/eedb98dc-0802-4102-8b71-abfc19b5ad5c"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3c2243ec-a10f-4aab-aaf9-99153d805455_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a0ee38d-7417-4fdc-9052-3fcc64dad96c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"Family 4","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/6a0ee38d-7417-4fdc-9052-3fcc64dad96c","type":"Family","rdfs:label":"Family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/3e15ba7f-ed77-4eae-be73-fc49a366fb48"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"HP:0010622,HP:0002652","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002652","obo:HP_0010622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3e15ba7f-ed77-4eae-be73-fc49a366fb48"}},{"id":"https://genegraph.clinicalgenome.org/r/475f0dca-7157-46cf-a2fa-59dba623ffee_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"Family 1","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/475f0dca-7157-46cf-a2fa-59dba623ffee","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/ce6b024b-199f-44c0-b56d-d927b78add1f"}},"meetsInclusionCriteria":true,"phenotypeFreeText":" ","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002652","obo:HP_0010622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ce6b024b-199f-44c0-b56d-d927b78add1f"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b43ac6b9-ef68-4c58-aea1-5fb536a6e3fc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"Family 5","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/b43ac6b9-ef68-4c58-aea1-5fb536a6e3fc","type":"Family","rdfs:label":"Family 5","member":{"id":"https://genegraph.clinicalgenome.org/r/3c9ca6be-2216-4209-b7c4-bcc2e6ae90db"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0003084","obo:HP_0001324"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3c9ca6be-2216-4209-b7c4-bcc2e6ae90db"}},{"id":"https://genegraph.clinicalgenome.org/r/8897f830-eb3c-43c5-a762-bde71c0907fa_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"Family 3","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/8897f830-eb3c-43c5-a762-bde71c0907fa","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/480f0b36-a422-45a9-9f8d-b74c1237d760"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002652","obo:HP_0010622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/480f0b36-a422-45a9-9f8d-b74c1237d760"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/34f56702-cc40-49d3-a8ea-7fab79171c60_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464254","rdfs:label":"Family 2 ","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/34f56702-cc40-49d3-a8ea-7fab79171c60","type":"Family","rdfs:label":"Family 2 ","member":{"id":"https://genegraph.clinicalgenome.org/r/0ebc5977-2c67-4c41-b70e-01608cb22324"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Skeletal dysplasia, bone dysplasia, bone cancer (neoplasm of skeletal system)","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0010622","obo:HP_0002652"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0ebc5977-2c67-4c41-b70e-01608cb22324"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Moderate","sequence":2951,"specifiedBy":"GeneValidityCriteria8","strengthScore":8.25,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JscjKTVMuos","type":"GeneValidityProposition","disease":"obo:MONDO_0007205","gene":"hgnc:7413","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3c2243ec-a10f-4aab-aaf9-99153d805455-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}